Processa Pharmaceuticals’ stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises milestone payments and royalties for Processa.
Processa Pharmaceuticals’ stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises milestone payments and royalties for Processa.
Copyright © Louis Velazquez. All Rights Reserved.